Robert Andrew Eckert
Lead Independent DirectorMr. Robert Andrew Eckert, MBA, also known as Andy, is Chairman of the Board at Ergomed Group Limited from 2026. He has been Lead Independent Director of Becton, Dickinson and Company since January 27, 2026. He was Independent Director of Becton, Dickinson and Company from September 26, 2016 until January 27, 2026. He is Director of Vantive Health LLC from 2026. He is Chairman of Lytx, Inc since July 2025 and served as its Interim Chief Executive Officer until July 2025. He serves as Senior Adviser at Permira Advisers Ltd since joining the firm on December 6, 2022. He is a proven leader across multiple sectors of healthcare, including Medical Devices, HCIT and Services. He is Chairman of the Board at Maravai LifeSciences Holdings, Inc. since December 05, 2024. He is a Member of Advisory Board of Grant Avenue Capital, LLC. He is Executive Chairman of Kipu. He served as Lead Independent Director at Fortrea Holdings Inc. since July 2023 until February 21, 2025. He is Director of Vyaire Medical Incorporated. From April 2017 until the sale of the company in October 2019, he served as President and Chief Executive Officer of Acelity L.P. Inc. He served as Chief Executive Officer at Zelis Healthcare Inc. since August 2020 until August 2021. He served as an Executive Advisor at LRVHealth. He served as the Chief Executive Officer of Valence Health, Inc. from August 03, 2015, to November 3, 2016. Prior to Valence, he served as the Chief Executive Officer of TriZetto Corporation since March 17, 2014 until November 2014. He served as the Chief Executive Officer of CRC Health Group, Inc. from January 2011 to March 17, 2014. He served as the Chief Executive Officer of CRC Health Corporation from January 3, 2011 to March 14, 2014. He has an extensive background in operational and fiscal management. He has a proven track record of success in both healthcare and enterprise software and has served as the Chief Executive Officer of private and publicly traded companies for the past several years. He served as the Managing Director from October 2009 to January 2011 and General Partner of Symphony Technology Group. He served as the President and Chief Executive Officer of Eclipsys Corporation from November 14, 2005 to May 13, 2009. He served as the Chief Executive Officer of SumTotal Systems, LLC from March 2004 to October 19, 2005. He served as the President at Docent Inc. from December 31, 2001, to March 2004. He joined Docent Inc. in December 2001 as the Chief Operating Officer and served as its Chief Executive Officer from April 2002 to March 2004. From 1990 to 2001, he served numerous executive positions at ADAC Laboratories including Chief Executive Officer from August 1997 to 2001. He joined ADAC Laboratories in February 1990. From 2000 to December 2001, he served as an Independent Consultant. He served as President and Chief Operating Officer of ADAC Laboratories from March 1997 to August 1997. From November 1994 to March 1997, he served as the President and General Manager at ADAC Medical Systems and from February 1992 to November 1994, he served as an Executive Vice President and General Manager of nuclear medicine business at ADAC. He served in the consulting, finance, venture capital and investment banking industries with Goldman, Sachs & Co. He was employed at Summit Partners. He serves as Chairman of CRC Health Group, Inc. He has been the Chairman of CRC Health Corporation since November 2012. He has been the Chairman of Varian Medical Systems, Inc. since February 20, 2014 and has been its Independent Director since October 15, 2004. He served as the Chairman of ADAC Laboratories, from April 1999 to December 2000. He has been a Director of Valence Health, Inc. since August 03, 2015 and Acelity L.P. Inc. since April 2017. He has been a Director of CRC Health Corporation since January 2011. He served as Director of Docent Inc. from May 2002 to March 2004. He served as a Lead Director at Varian Medical Systems, Inc. He is a leader in the growing field of health care information technology, with extensive experience as an executive officer of several healthcare companies. He served as Director of SumTotal Systems, LLC from March 2004 to October 19, 2005. He served financial and strategic planning positions at Marakon Associates, Inc. in San Francisco. He served as a Director of Awarepoint Corporation since February 8, 2012. He served as a Director of Eclipsys India since November 14, 2005. He served as a Director of Connetics Corporation since December 2002 and Chordiant Software, Inc. from September 2, 2003 to June 1, 2005. He served as a Director of Eclipsys Corporation from November 14, 2005, to May 13, 2009. He served as a Director of ADAC Laboratories from April 1996 to December 2000. He serves as Co-Chairman of the Pacific Vascular Research Foundation. He is a Fellow of the College of Nuclear Medicine. He holds an M.B.A. from Stanford University's Graduate School of Business in 1988 and a Bachelor of Science in Industrial Engineering from Stanford University in 1983.
Positions
- Company NameBecton, Dickinson and CompanyStock CodeBDXPositionLead Independent DirectorColleagues
- TEThomas E. PolenPresident, CEO & Chairman
- MCMichael C. FeldExecutive VP & Chief Revenue Officer
- VRVitor RoqueExecutive VP & CFO
- EMElizabeth McCombsExecutive VP & CTO
- JMJoseph M. SmithSenior VP & Chief Scientific Officer
- CIChristopher Ian Montague JonesIndependent Director
- CMCatherine M. BurzikIndependent Director
- JWJeffrey W. HendersonIndependent Director
- Company NameMaravai LifeSciences Holdings, Inc.Stock CodeMRVIPositionChairman of the BoardColleagues
- RARobert Andrew EckertChairman of the Board
- BBBernd BrustCEO & Director
- RJRajesh J. AsorpotaEVP & Chief Financial Officer
- KAKurt A. OreshackExecutive VP, General Counsel & Secretary
- CDChristine DolanExecutive VP & GM of Cygnus Technologies
- SGSusannah GrayIndependent Director
- JAJohn A. DeFordIndependent Director
- GTGregory Thomas LucierIndependent Director
